Last reviewed · How we verify
THC 5
At a glance
| Generic name | THC 5 |
|---|---|
| Also known as | Tetrahydrocannabinol, Dronabinol, Cannabis, Ripple Blood Orange Gummies (Stillwater Brands, Commerce City, CO). |
| Sponsor | Lakehead University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dronabinol in Total Knee Arthroplasty (TKA) (PHASE4)
- Age Differences in the Effects of Cannabis on Simulated Driving (NA)
- AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) (PHASE1)
- Effects of Dronabinol in Opioid Maintained Patients (EARLY_PHASE1)
- Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance (PHASE1)
- Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment (PHASE2)
- Unique Treatment of Oncology Pain in Advanced Cancer (PHASE2)
- PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- THC 5 CI brief — competitive landscape report
- THC 5 updates RSS · CI watch RSS
- Lakehead University portfolio CI